|
UBE2N expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.18380000000163E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.93890000000008E-05 |
| Normal-vs-Stage2 |
3.932200E-02 |
| Normal-vs-Stage3 |
3.598300E-02 |
| Normal-vs-Stage4 |
2.247600E-01 |
| Stage1-vs-Stage2 |
7.142200E-01 |
| Stage1-vs-Stage3 |
3.851200E-01 |
| Stage1-vs-Stage4 |
3.230800E-01 |
| Stage2-vs-Stage3 |
7.404400E-01 |
| Stage2-vs-Stage4 |
5.332800E-01 |
| Stage3-vs-Stage4 |
6.748600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.4694999999928E-06 |
| Normal-vs-AfricanAmerican |
6.176300E-02 |
| Normal-vs-Asian |
3.228000E-01 |
| Caucasian-vs-AfricanAmerican |
3.925900E-02 |
| Caucasian-vs-Asian |
1.460140E-02 |
| AfricanAmerican-vs-Asian |
6.612800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.44510000002585E-06 |
| Normal-vs-Female |
6.605600E-02 |
| Male-vs-Female |
1.824210E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.280000E-03 |
| Normal-vs-Extreme_Weight |
3.74280000003946E-06 |
| Normal-vs-Obese |
3.629800E-04 |
| Normal-vs-Extreme_Obese |
1.787790E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.158600E-01 |
| Normal_Weight-vs-Obese |
7.242800E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.724800E-01 |
| Extreme_Weight-vs-Obese |
4.903200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.046000E-01 |
| Obese-vs-Extreme_Obese |
3.409400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.032200E-01 |
| Normal-vs-Age(41-60Yrs) |
2.041900E-03 |
| Normal-vs-Age(61-80Yrs) |
2.0969999999787E-06 |
| Normal-vs-Age(81-100Yrs) |
2.560900E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.057990E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.397540E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.622400E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.076300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.506100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.808400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.184300E-04 |
| Normal-VS-Type2 PRCC |
2.09219999991461E-07 |
| Normal-VS-KIRP CIMP |
6.980400E-01 |
| Normal-VS-Unclassified PRCC |
1.371710E-02 |
| Type1 PRCC-VS-Type2 PRCC |
5.075200E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.411850E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.042600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.343000E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
3.486500E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.946240E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.55119999998033E-06 |
| Normal-vs-N1 |
2.388600E-01 |
| Normal-vs-N2 |
3.489500E-02 |
| N0-vs-N1 |
4.403700E-03 |
| N0-vs-N2 |
9.127600E-01 |
| N1-vs-N2 |
2.097600E-01 |
|
|
